Impact of Scleral Contact Lens Wear on Corneal Nerves in Keratoconus
NCT ID: NCT03091101
Last Updated: 2018-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2017-03-15
2018-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corneal Thickness Changes With Scleral Contact Lenses
NCT03249233
KeratoConus Data Acquisition With Topography and Aberrometry
NCT06859398
Changes in the Tear Film With Scleral Contact Lens Wear for Keratoconic Eyes
NCT02806921
Efficacy of Scleral Contact Lenses for Daily Wear for Regular and Irregular Refractive Errors Compared to Habitually Worn Scleral Lenses
NCT02643095
Ocular Effects of Scleral Lens Wear on Dry Eye Patients
NCT05079321
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to investigate changes in corneal innervation during scleral contact lens wear in a keratoconic population. Specifically, changes in corneal sensitivity and nerve fiber density from baseline in the central and mid-peripheral corneal locations will be measured over a 6-month lens wear period. An additional aim of the study is to investigate the impact of scleral lens wear on corneal inflammation within the same study group. This will be achieved by comparing dendritic cell density change from baseline over the study period.
The investigators propose to take a sample of keratoconic participants and fit them in scleral lenses and:
1. Measure corneal sensitivity at two corneal locations before and after 1-month, 3-months and 6-months of scleral lens wear.
2. Capture images of the sub-basal nerve plexus in vivo using laser-scanning confocal microscopy at similar corneal locations and study visits.
3. Calculate nerve morphology parameters and dendritic cell density from these captured images.
Up to 15 participants will be enrolled.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scleral lens wearing keratoconics
Newly diagnosed keratoconics with no previous rigid lens wear fitted with Sceral contact lenses
Scleral lens wearing keratoconics
Cohort of keratoconics fitted with scleral lenses and monitored over 6 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scleral lens wearing keratoconics
Cohort of keratoconics fitted with scleral lenses and monitored over 6 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Is at least 18 years of age and has full legal capacity to volunteer.
* Has read and understood the information consent letter.
* Is willing and able to follow instructions and maintain the appointment schedule.
Exclusion Criteria
* Is using any topical medications that will affect ocular health.
* Has any ocular pathology or systemic disease that may lead to severe insufficiency of lacrimal secretion (severe dry eyes) or corneal hypoesthesia which would affect the wearing of contact lenses.
* Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
* Has any clinically significant lid or conjunctival abnormalities and active neovascularization.
* Is aphakic.
* Has undergone any corneal surgery.
* Is participating in any other type of eye related clinical or research study.
* Has any known allergies or sensitivity to the diagnostic pharmaceuticals or products, such as fluorescein and topical anesthetics, used in this study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Precision Technology Services Ltd
UNKNOWN
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edward Lum
Post-Doctorial Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edward Lum, PhD
Role: PRINCIPAL_INVESTIGATOR
Univerity of Waterloo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Optometry and Vision Science
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORE#21910
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.